A citation-based method for searching scientific literature

Erkut Borazanci, Ronald Korn, Winnie S Liang, Carol Guarnieri, Susan Haag, Courtney Snyder, Kristin Hendrickson, Lana Caldwell, Dan Von Hoff, Gayle Jameson. Oncologist 2020
Times Cited: 4







List of co-cited articles
16 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Next-generation computational tools for interrogating cancer immunity.
Francesca Finotello, Dietmar Rieder, Hubert Hackl, Zlatko Trajanoski. Nat Rev Genet 2019
55
25

Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features.
Francesco Puleo, Rémy Nicolle, Yuna Blum, Jérôme Cros, Laetitia Marisa, Pieter Demetter, Eric Quertinmont, Magali Svrcek, Nabila Elarouci, Juan Iovanna,[...]. Gastroenterology 2018
162
25

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.
Da Wei Huang, Brad T Sherman, Richard A Lempicki. Nat Protoc 2009
25

Determining cell type abundance and expression from bulk tissues with digital cytometry.
Aaron M Newman, Chloé B Steen, Chih Long Liu, Andrew J Gentles, Aadel A Chaudhuri, Florian Scherer, Michael S Khodadoust, Mohammad S Esfahani, Bogdan A Luca, David Steiner,[...]. Nat Biotechnol 2019
492
25

Patients with hepatic oligometastatic pancreatic body/tail ductal adenocarcinoma may benefit from synchronous resection.
Jianyu Yang, Junfeng Zhang, Wei Lui, Yanmiao Huo, Xueliang Fu, Minwei Yang, Rong Hua, Liwei Wang, Yongwei Sun. HPB (Oxford) 2020
8
25

Understanding the Warburg effect: the metabolic requirements of cell proliferation.
Matthew G Vander Heiden, Lewis C Cantley, Craig B Thompson. Science 2009
25

Adaptation of energy metabolism in breast cancer brain metastases.
Emily I Chen, Johannes Hewel, Joseph S Krueger, Claire Tiraby, Martin R Weber, Anastasia Kralli, Katja Becker, John R Yates, Brunhilde Felding-Habermann. Cancer Res 2007
221
25

Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC).
Sreenivasa Chandana, Hani M Babiker, Daruka Mahadevan. Expert Opin Investig Drugs 2019
29
25

Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma.
Nicole M A White, Daniel W Newsted, Olena Masui, Alexander D Romaschin, K W Michael Siu, George M Yousef. Tumour Biol 2014
24
25

GSVA: gene set variation analysis for microarray and RNA-seq data.
Sonja Hänzelmann, Robert Castelo, Justin Guinney. BMC Bioinformatics 2013
25

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.
Craig H Mermel, Steven E Schumacher, Barbara Hill, Matthew L Meyerson, Rameen Beroukhim, Gad Getz. Genome Biol 2011
25

Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.
Ashton A Connor, Robert E Denroche, Gun Ho Jang, Mathieu Lemire, Amy Zhang, Michelle Chan-Seng-Yue, Gavin Wilson, Robert C Grant, Daniele Merico, Ilinca Lungu,[...]. Cancer Cell 2019
65
25

Molecular profiling of driver events in metastatic uveal melanoma.
Joakim Karlsson, Lisa M Nilsson, Suman Mitra, Samuel Alsén, Ganesh Vilas Shelke, Vasu R Sah, Elin M V Forsberg, Ulrika Stierner, Charlotta All-Eriksson, Berglind Einarsdottir,[...]. Nat Commun 2020
38
25

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.
Daniel C Koboldt, Qunyuan Zhang, David E Larson, Dong Shen, Michael D McLellan, Ling Lin, Christopher A Miller, Elaine R Mardis, Li Ding, Richard K Wilson. Genome Res 2012
25

The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V Liberti, Jason W Locasale. Trends Biochem Sci 2016
25

Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential.
Andrew Cannon, Christopher Thompson, Bradley R Hall, Maneesh Jain, Sushil Kumar, Surinder K Batra. Genes Cancer 2018
32
25

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
25

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.
Ping Gao, Irina Tchernyshyov, Tsung-Cheng Chang, Yun-Sil Lee, Kayoko Kita, Takafumi Ochi, Karen I Zeller, Angelo M De Marzo, Jennifer E Van Eyk, Joshua T Mendell,[...]. Nature 2009
25

Tumor microenvironment participates in metastasis of pancreatic cancer.
Bo Ren, Ming Cui, Gang Yang, Huanyu Wang, Mengyu Feng, Lei You, Yupei Zhao. Mol Cancer 2018
132
25

Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.
Sebastian Mueller, Thomas Engleitner, Roman Maresch, Magdalena Zukowska, Sebastian Lange, Thorsten Kaltenbacher, Björn Konukiewitz, Rupert Öllinger, Maximilian Zwiebel, Alex Strong,[...]. Nature 2018
167
25

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.
Michael I Love, Wolfgang Huber, Simon Anders. Genome Biol 2014
25

Mouse models of metastasis: progress and prospects.
Laura Gómez-Cuadrado, Natasha Tracey, Ruoyu Ma, Binzhi Qian, Valerie G Brunton. Dis Model Mech 2017
121
25

IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia.
Yuliya Pylayeva-Gupta, Shipra Das, Jesse S Handler, Cristina H Hajdu, Maryaline Coffre, Sergei B Koralov, Dafna Bar-Sagi. Cancer Discov 2016
156
25

Chromosome 3p Loss-Orchestrated VHL, HIF, and Epigenetic Deregulation in Clear Cell Renal Cell Carcinoma.
James J Hsieh, Valerie H Le, Toshinao Oyama, Christopher J Ricketts, Thai Huu Ho, Emily H Cheng. J Clin Oncol 2018
47
25

Genomic Gain of 16p13.3 in Prostate Cancer Predicts Poor Clinical Outcome after Surgical Intervention.
Yogesh M Bramhecha, Karl-Philippe Guérard, Shaghayegh Rouzbeh, Eleonora Scarlata, Fadi Brimo, Simone Chevalier, Lucie Hamel, Alice Dragomir, Armen G Aprikian, Jacques Lapointe. Mol Cancer Res 2018
5
25

Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases.
Di Wang, Xiaohui Niu, Zhijie Wang, Cheng-Li Song, Zhen Huang, Ke-Neng Chen, Jianchun Duan, Hua Bai, Jiachen Xu, Jun Zhao,[...]. Cancer Res 2019
53
25

The paradoxical roles of C1q and C3 in autoimmunity.
Diane Scott, Marina Botto. Immunobiology 2016
29
25

Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma.
Junya Peng, Bao-Fa Sun, Chuan-Yuan Chen, Jia-Yi Zhou, Yu-Sheng Chen, Hao Chen, Lulu Liu, Dan Huang, Jialin Jiang, Guan-Shen Cui,[...]. Cell Res 2019
175
25

Pancreatic Cancer Metastases Harbor Evidence of Polyclonality.
Ravikanth Maddipati, Ben Z Stanger. Cancer Discov 2015
150
25

HTSeq--a Python framework to work with high-throughput sequencing data.
Simon Anders, Paul Theodor Pyl, Wolfgang Huber. Bioinformatics 2015
25

Oncotator: cancer variant annotation tool.
Alex H Ramos, Lee Lichtenstein, Manaswi Gupta, Michael S Lawrence, Trevor J Pugh, Gordon Saksena, Matthew Meyerson, Gad Getz. Hum Mutat 2015
291
25

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.
Kristian Cibulskis, Michael S Lawrence, Scott L Carter, Andrey Sivachenko, David Jaffe, Carrie Sougnez, Stacey Gabriel, Matthew Meyerson, Eric S Lander, Gad Getz. Nat Biotechnol 2013
25

BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor.
Jeanette E Eckel-Passow, Daniel J Serie, John C Cheville, Thai H Ho, Payal Kapur, James Brugarolas, R Houston Thompson, Bradley C Leibovich, Eugene D Kwon, Richard W Joseph,[...]. BMC Urol 2017
13
25

Strelka2: fast and accurate calling of germline and somatic variants.
Sangtae Kim, Konrad Scheffler, Aaron L Halpern, Mitchell A Bekritsky, Eunho Noh, Morten Källberg, Xiaoyu Chen, Yeonbin Kim, Doruk Beyter, Peter Krusche,[...]. Nat Methods 2018
288
25

The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.
Aaron McKenna, Matthew Hanna, Eric Banks, Andrey Sivachenko, Kristian Cibulskis, Andrew Kernytsky, Kiran Garimella, David Altshuler, Stacey Gabriel, Mark Daly,[...]. Genome Res 2010
25

Advances in oligonucleotide drug delivery.
Thomas C Roberts, Robert Langer, Matthew J A Wood. Nat Rev Drug Discov 2020
234
25

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
25

ATM-Deficient Cancers Provide New Opportunities for Precision Oncology.
Nicholas R Jette, Mehul Kumar, Suraj Radhamani, Greydon Arthur, Siddhartha Goutam, Steven Yip, Michael Kolinsky, Gareth J Williams, Pinaki Bose, Susan P Lees-Miller. Cancers (Basel) 2020
36
25

Dramatic response to PARP inhibition in a PALB2-mutated breast cancer: moving beyond BRCA.
T Grellety, F Peyraud, N Sevenet, O Tredan, N Dohollou, E Barouk-Simonet, M Kind, M Longy, J-Y Blay, A Italiano. Ann Oncol 2020
11
25

A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas.
Jeffrey R Infante, Bradley G Somer, Joon Oh Park, Chung-Pin Li, Max E Scheulen, Saifuddin M Kasubhai, Do-Youn Oh, Yuan Liu, Suman Redhu, Klaudia Steplewski,[...]. Eur J Cancer 2014
183
25

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
Alexander Drilon, Theodore W Laetsch, Shivaani Kummar, Steven G DuBois, Ulrik N Lassen, George D Demetri, Michael Nathenson, Robert C Doebele, Anna F Farago, Alberto S Pappo,[...]. N Engl J Med 2018
25

Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
Spring Holter, Ayelet Borgida, Anna Dodd, Robert Grant, Kara Semotiuk, David Hedley, Neesha Dhani, Steven Narod, Mohammad Akbari, Malcolm Moore,[...]. J Clin Oncol 2015
213
25

Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review.
Ghulam Rehman Mohyuddin, Muhammad Aziz, Alec Britt, Lee Wade, Weijing Sun, Joaquina Baranda, Raed Al-Rajabi, Anwaar Saeed, Anup Kasi. BMC Cancer 2020
17
25

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.
David M Hyman, Igor Puzanov, Vivek Subbiah, Jason E Faris, Ian Chau, Jean-Yves Blay, Jürgen Wolf, Noopur S Raje, Eli L Diamond, Antoine Hollebecque,[...]. N Engl J Med 2015
25

MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells.
Gregory V Kryukov, Frederick H Wilson, Jason R Ruth, Joshiawa Paulk, Aviad Tsherniak, Sara E Marlow, Francisca Vazquez, Barbara A Weir, Mark E Fitzgerald, Minoru Tanaka,[...]. Science 2016
201
25

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.
Aurelien Marabelle, Dung T Le, Paolo A Ascierto, Anna Maria Di Giacomo, Ana De Jesus-Acosta, Jean-Pierre Delord, Ravit Geva, Maya Gottfried, Nicolas Penel, Aaron R Hansen,[...]. J Clin Oncol 2020
519
25

ATM-Mutated Pancreatic Cancer: Clinical and Molecular Response to Gemcitabine/Nab-Paclitaxel After Genome-Based Therapy Resistance.
Candice Martino, Deep Pandya, Ronald Lee, Gillian Levy, Tammy Lo, Sandra Lobo, Richard C Frank. Pancreas 2020
6
25

Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.
Sushrut Kamerkar, Valerie S LeBleu, Hikaru Sugimoto, Sujuan Yang, Carolina F Ruivo, Sonia A Melo, J Jack Lee, Raghu Kalluri. Nature 2017
846
25


EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer.
Vito Amodio, Rona Yaeger, Pamela Arcella, Carlotta Cancelliere, Simona Lamba, Annalisa Lorenzato, Sabrina Arena, Monica Montone, Benedetta Mussolin, Yu Bian,[...]. Cancer Discov 2020
62
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.